March 27th Options Now Available For NVIDIA

At NVDA's current price of $172.75, a $155 strike put is bid at $5.10 — selling-to-open would commit the seller to buy at $155 with an effective cost basis of $149.90 and is out‑of‑the‑money by ~10%; analytics put the odds it expires worthless at 74%, implying a 3.29% return (24.04% annualized). On the call side, a $180 strike is bid at $8.60 — selling a covered call from $172.75 would deliver a 9.18% total return if called at the March 27 expiration and has a 54% chance to expire worthless, representing a 4.98% yield boost (36.37% annualized). Implied volatilities are 59% (put) and 47% (call) versus a 12‑month trailing volatility of 44%; Stock Options Channel will track the contract odds and trading history on its site.

Analysis

Market structure: Option sellers and income-focused retail/ETF strategies win short-term from elevated implied volatility (put IV 59% vs realized 44%), collecting outsized premia (put: $5.10, covered-call: $8.60). Buyers of NVDA shares who want a cheaper entry also benefit via cash‑secured puts (effective basis $149.90). The skew (put IV > call IV) signals asymmetric demand for downside protection and a short-tail risk premium concentrated in NVDA and the semiconductor complex.

Risk assessment: Tail risks include an earnings shock, export/regulatory action limiting China sales, or a macro growth shock that could push realized vol >70% and trigger assignment/margin cascades in crowded short‑vol positions. Near-term (days–weeks) theta decay favors sellers into the March 27 expiry; medium term (1–3 months) depends on guidance and macro prints; long term (quarters) fundamentals (AI demand) still support upside but hinge on unit/ASP sustainability. Hidden risks: assignment risk, collateral opportunity cost ($15,500 per put contract), and crowded option‑selling creating nonlinear gamma exposure.

Trade implications: Direct play — establish cash‑secured short NVDA 155 put (Mar‑27) collecting $5.10 if willing to own at $149.90; limit position to 1–2% NAV (one contract ≈ $15,500 obligation). Alternative — buy NVDA and sell Mar‑27 180 call to harvest 9.18% to assignment; size similarly and close if NVDA >185 or IV compresses below 40%. Use pair trade: long NVDA / short SOXX (dollar‑neutral at 0.6 SOXX per $1 NVDA) to isolate company outperformance. For protection consider a 6‑month 150/130 put spread if cost <3.5% of notional.

Contrarian angles: The market overlooks crowding risk in short‑put sellers — a <26% chance of assignment per current analytics still underestimates correlated shocks. The IV premium may be underpriced relative to event risk (earnings/guidance) so short‑vol strategies are vulnerable to rapid IV spikes; historically NVDA has seen post‑earnings IV crush then follow‑through rallies, not permanent downside. Unintended consequence: rising assignment could force cap‑allocation switches and create buying into weakness — a tactical long on pullbacks into $150–160 could be asymmetric reward.

Key Decisions for Investors

• Sell-to-open 1 cash‑secured NVDA Mar‑27 155 put (collect $5.10) sized to 1% of portfolio (~$15,500 cash reserve per contract). Close or roll if NVDA <150 or if IV rises >10 pts from entry; otherwise hold to expiry to realize ~3.3% premium (annualized ~24%).
• Buy NVDA at market and sell-to-open Mar‑27 180 covered call (collect $8.60) for a 9.18% return to assignment; cap at 1–2% portfolio weight, buy-to-close the call if NVDA >185 or if IV falls below 40 to avoid losing upside capture.
• Establish a hedged pair trade: long NVDA exposure (target 1% NAV) paired with short SOXX equal-dollar at 0.6 ratio to strip sector beta; rebalance weekly and unwind if spread widens >5% or NVDA triggers >10% gap moves.
• If concerned about a downside shock, buy a 6‑month NVDA 150/130 put spread sized to 0.5–1% NAV only if premium is <3.5% of notional; this caps downside risk while keeping participation in AI-driven upside.